Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

ClinicalTrials.gov ID: NCT00000620

Public ClinicalTrials.gov record NCT00000620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 6:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00000620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
10,251 participants

Conditions and interventions

Interventions

  • Anti-hyperglycemic Agents Drug
  • Anti-hypertensive Agents Drug
  • Blinded fenofibrate or placebo plus simvastatin Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 1999
Primary completion
May 31, 2009
Completion
Nov 30, 2012
Last update posted
Nov 21, 2016

1999 – 2012

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Minneapolis Medical Research Foundation Minneapolis Minnesota 55404
Columbia University New York New York 10027
Wake Forest University Winston-Salem North Carolina 27106
Case Western Reserve University Cleveland Ohio 44106
Veterans Affairs Memphis Tennessee 38104
University of Washington Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2016 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →